Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Roth A, Barcellini W, Ademokun C, Jang J, Lozano ML, Ferreiras DV, Pascual-Izquierdo C, Chitnis S, Matviykiv S, Vitaliti A, Chen C, Katsanou V, Chawla R, Al-Samkari H. Iptacopan for Immune Thrombocytopenia and Cold Agglutinin Disease: A Global Phase 2 Basket Clinical Trial. Am J Hematol. 2026 Feb;101(2):242-254. doi: 10.1002/ajh.70147. Epub 2025 Dec 9. PubMed PMID: 41366634; PubMed Central PMCID: PMC12766356.
AÑO: 2026; IF: 9.9
41366634
Ugarteburu O, Farre-Tarrats L, Munoz-Pujol G, Unceta M, Las Heras J, Garcia-Ribes A, Arza-Ruesga A, de la Morena B, Arauz-Garofalo G, Gay M, Garrabou G, Corral J, Vilaseca M, Ribes A, Garcia-Villoria J, Gort L, Tort F. Complex IV deficiency due to COX4I1 deep intronic and de novo variants results in progressive motor impairment and Leigh syndrome. Mitochondrion. 2026 Jan;86:102095. doi: 10.1016/j.mito.2025.102095. Epub 2025 Nov 5. PubMed PMID: 41203052.
AÑO: 2026; IF: 4.5
41203052
Diaz-Ajenjo L, Marin-Quilez A, Lama-Villanueva A, Garcia-Jaen P, Rey-Bua B, Hernandez-Rivas JM, Morgan NV, Gonzalez-Porras JR, Benito R, Rivera J, Bastida JM. A novel homozygous splice-site variant in VPS33B identified as a cause of bleeding. J Thromb Haemost. 2026 Jan;24(1):146-154. doi: 10.1016/j.jtha.2025.09.036. Epub 2025 Oct 23. PubMed PMID: 41138802.
AÑO: 2026; IF: 5.0
41138802
Soler-Espejo E, Zazo-Luengo BA, Rivera-Caravaca JM, Lopez-Gavez R, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation. J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29. PubMed PMID: 39615399.
AÑO: 2025; IF: 4.0
39615399
Castano-Diez S, Lopez-Guerra M, Zugasti I, Calvo X, Schulz FI, Avendano A, Mora E, Falantes J, Azaceta G, Ibanez M, Chen T, Notario C, Amer N, Palomo L, Pomares H, Vila J, Bernal Del Castillo T, Jimenez-Vicente C, Esteban D, Guijarro F, Alamo J, Cortes-Bullich A, Torrecillas-Mayayo V, Triguero A, Mont-de Torres L, Carcelero E, Cardus A, Germing U, Betz B, Rozman M, Arenillas L, Zamora L, Diez-Campelo M, Xicoy B, Esteve J, Diaz-Beya M. AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular. Blood Adv. 2025 Jan 14;9(1):39-53. doi: 10.1182/bloodadvances.2024013648. PubMed PMID: 39388660.
AÑO: 2025; IF: 7.1
39388660
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL